Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Sep 2020

  Comment

  5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19.

  Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382:2441-8. 32356628.

  expand abstract… mark as read…

• Ann. Intern. Med. · Sep 2020

  Comment

  In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortality.

  Chiarito M, Sanz-Sánchez J, Cannata F, et al. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. Lancet. 2020;395;1487-95. 32386592.

  read more… mark as read…

• Ann. Intern. Med. · Sep 2020

  Editorial

  Blood Transfusion Safety in Low-Resourced Countries: Aspiring to a Higher Standard.

  no abstract available

  read on… mark as read…

• Ann. Intern. Med. · Sep 2020

  Comment

  Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF.

  Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382:1883-93. 32222134.

  read more… or not…

• Ann. Intern. Med. · Sep 2020

  Comment

  In ischemic stroke, thrombectomy alone was noninferior to thrombectomy plus alteplase for functional outcome at 90 days.

  Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020;382:1981-93. 32374959.

  read more… or not…